Once-weekly exenatide as a treatment for Type 2 diabetes.

about

Once-weekly exenatide as a treatment for Type 2 diabetes.

Item

http://www.wikidata.org/entity/Q38497691

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Once-weekly exenatide as a treatment for Type 2 diabetes.

@en

type

Item

label

Once-weekly exenatide as a treatment for Type 2 diabetes.

@en

prefLabel

Once-weekly exenatide as a treatment for Type 2 diabetes.

@en

P1476

Once-weekly exenatide as a treatment for Type 2 diabetes.

@en

P2093

Carrie McAdam-Marx

http://www.w3.org/2001/XMLSchema#string

Holly Gurgle

http://www.w3.org/2001/XMLSchema#string

Marisa B Schauerhamer

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial.

Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus.

The role of adjunctive exenatide therapy in pediatric type 1 diabetes.

Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years.

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

P304

611-626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2015.1038242

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26000560

http://www.w3.org/2001/XMLSchema#string

Once-weekly exenatide as a treatment for Type 2 diabetes.

about

Once-weekly exenatide as a treatment for Type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698